Teva Pharmaceutical Industries Ltd (TEVA)
14.06
+0.08
(+0.57%)
USD |
NYSE |
May 06, 16:00
14.06
0.00 (0.00%)
After-Hours: 20:00
Teva Pharmaceutical Industries Cash from Financing (Quarterly): -576.00M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -576.00M |
| September 30, 2023 | -576.00M |
| June 30, 2023 | -55.00M |
| March 31, 2023 | -706.00M |
| December 31, 2022 | -711.00M |
| September 30, 2022 | -440.00M |
| June 30, 2022 | -338.00M |
| March 31, 2022 | 2.00M |
| December 31, 2021 | -501.00M |
| September 30, 2021 | -1.177B |
| June 30, 2021 | -1.00M |
| March 31, 2021 | -493.00M |
| December 31, 2020 | -125.00M |
| September 30, 2020 | -1.057B |
| June 30, 2020 | -3.00M |
| March 31, 2020 | -700.00M |
| December 31, 2019 | -241.00M |
| September 30, 2019 | -1.461B |
| June 30, 2019 | -35.00M |
| March 31, 2019 | -189.00M |
| December 31, 2018 | -499.00M |
| September 30, 2018 | -705.00M |
| June 30, 2018 | -56.00M |
| March 31, 2018 | -2.091B |
| December 31, 2017 | -2.506B |
| Date | Value |
|---|---|
| September 30, 2017 | -825.00M |
| June 30, 2017 | -651.00M |
| March 31, 2017 | -1.768B |
| December 31, 2016 | -701.00M |
| September 30, 2016 | 25.37B |
| June 30, 2016 | 279.00M |
| March 31, 2016 | 267.00M |
| December 31, 2015 | 4.715B |
| September 30, 2015 | -1.09B |
| June 30, 2015 | 1.087B |
| March 31, 2015 | 93.00M |
| December 31, 2014 | -593.00M |
| September 30, 2014 | -329.00M |
| June 30, 2014 | -819.00M |
| March 31, 2014 | -634.00M |
| December 31, 2013 | -619.00M |
| September 30, 2013 | -256.00M |
| June 30, 2013 | -748.00M |
| March 31, 2013 | -2.26B |
| December 31, 2012 | 266.00M |
| September 30, 2012 | -570.00M |
| June 30, 2012 | -761.00M |
| March 31, 2012 | -613.00M |
| December 31, 2011 | 4.092B |
| September 30, 2011 | 698.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.461B
Minimum
Sep 2019
2.00M
Maximum
Mar 2022
-483.89M
Average
-493.00M
Median
Mar 2021
Cash from Financing (Quarterly) Benchmarks
| Viatris Inc | -926.10M |
| Alvotech | 20.66M |
| AstraZeneca PLC | 2.028B |
| Corcept Therapeutics Inc | 0.766M |
| GSK PLC | -1.344B |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.184B |
| Cash from Investing (Quarterly) | 301.00M |
| Free Cash Flow | 842.00M |
| Free Cash Flow Per Share (Quarterly) | 0.9517 |
| Free Cash Flow to Equity (Quarterly) | 1.206B |
| Free Cash Flow to Firm (Quarterly) | 1.327B |
| Free Cash Flow Yield | 5.34% |